Skip to content

Archives

Bank of america healthcare conference 2019 las vegas


bank of america healthcare conference 2019 las vegas

it will present at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, , at the Encore Wynn Hotel, Las Vegas, NV. Bank of America Merrill Lynch Healthcare Conference. May 14, at PM PDT. Listen to Webcast. Location. Las Vegas, NV. at the Bank of America Merrill Lynch Health Care Conference May 16, AM PDT. at the Encore at Wynn hotel in Las Vegas, Nevada.

: Bank of america healthcare conference 2019 las vegas

Bank of america healthcare conference 2019 las vegas
Bank of america healthcare conference 2019 las vegas
WALMART EYE CENTER MEXICO MO
Bank of america healthcare conference 2019 las vegas
AMAZON COM STORE CARD

Press Release

ZUG, and(GLOBE NEWSWIRE) -- (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences later this month:

SunTrust Robinson Humphrey 5th Annual Life Sciences Summit
Date: Wednesday, May 8,
Location: New


Date: Wednesday, May 15,
Presentation:  p.m. PT
Location: Las Vegas, NV


Date: Tuesday, May 21,
Presentation:  a.m. ET
Location:

A live webcast of the events will be available on the "Events & Presentations" page in the Investors section of the Company's website at mynewextsetup.us A replay of the webcasts will be archived on the Company's website for 14 days following each presentation.

About
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 bank of america healthcare conference 2019 las vegas. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established bank of america healthcare conference 2019 las vegas collaborations with leading companies including Bayer AG, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge,and business offices in London. For more information, please visit mynewextsetup.us

CRISPR Investor Bank of america healthcare conference 2019 las vegas Media Contact:

WCG on behalf of CRISPR

[email protected]

mynewextsetup.us

Source: CRISPR Therapeutics AG

Источник: mynewextsetup.us

HealthEquity Sets Date to Announce First Quarter Results

Attend Investor Conferences

, (GLOBE NEWSWIRE) -- (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent HSA custodian, today announced that it plans to release its first quarter fiscal year financial results following the close of regular stock market trading hours on. Following the news release, management plans to host a conference call for investors onat during which management will review highlights from the Company’s first quarter results.

HealthEquity’s First Quarter Fiscal Year Conference Call
Date:June 4,
Time: p.m. Eastern Time / p.m. Mountain Time
Dial-In: (US and Canada)
(International)
Conference ID:
Webcast:mynewextsetup.us

The Company also announced that it plans to participate at the following upcoming investor conferences:

Bank of America Merrill Lynch Health Care Conference
Date:May 15,
Time: PM Pacific Time
Location:Las Vegas Encore Hotel
Presenters:Steve Neeleman, Founder and Vice Chair and Darcy Mott, EVP and CFO
Webcast:None
RBC Capital Markets Global Healthcare Conference
Date:May 21,
Location:InterContinental New York Barclay Hotel
1x1 Meetings:Darcy Mott, EVP and CFO and Tyson Murdock, SVP and Controller
Webcast:None

About

HealthEquity connects health and wealth, delivering health savings account (HSA) and other consumer driven health and retirement solutions in partnership with over 45, employers and health, retirement and other benefit plan providers nationwide. HealthEquity members have access to its end-to-end platform and remarkable “purple” service to become consumers of healthcare while building health and retirement savings for tomorrow. HealthEquity is the custodian of $ billion in assets for million HSA members nationwide. For more information, visit mynewextsetup.us

Forward-looking statements

This press release contains “forward-looking statements" within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act ofincluding but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.

Forward-looking statements reflect our current expectations regarding future events, nyseg customer service bill pay or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:

  • our ability to compete effectively in a rapidly evolving healthcare industry;
  • our dependence on the continued availability and benefits of tax-advantaged health savings accounts;
  • the significant competition we face and may face in the future, including from those with greater resources than us;
  • recent and potential future cybersecurity breaches of our union savings bank mt washington and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
  • the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
  • our ability to comply with current and future privacy, healthcare, tax, investment advisor and other laws applicable to our business;
  • our reliance on partners and third party vendors for distribution and important services;
  • our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
  • our ability to develop and implement updated features for our platform and successfully manage our growth;
  • our ability to protect our brand and other intellectual property rights; and
  • our reliance on our management team and key team members.

For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with theincluding, without limitation, our most recent Annual Report on Form K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investor Relations Contact:


[email protected]

mynewextsetup.us

Source: HealthEquity, Inc.

Источник: mynewextsetup.us

Homology Medicines to Present at Bank of America Merrill Lynch Health Care Conference

BEDFORD, Mass., May 9, – Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will participate during a fireside chat bank of america healthcare conference 2019 las vegas the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, at p.m. PT at the Encore Hotel in Las Vegas.  In addition, Arthur Tzianabos, Ph.D., President and Chief Executive Officer of Homology Medicines, will participate in the Gene Therapy Panel being held at the conference on Wednesday, May 15, at p.m. PT (not webcast).

The live webcast of the fireside chat will be accessible on Homology’s website in the Investors section, and the webcast replay will be available on the website for 90 days following the presentation.

About Homology Medicines, Inc.
Homology Medicines, Inc. is a genetic medicines company dedicated to bank of america healthcare conference 2019 las vegas the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines. For more information, please visit mynewextsetup.us

< BACKИсточник: mynewextsetup.us

The right guidance can unlock new possibilities. Watch our videos to see how having a Merrill bank of america healthcare conference 2019 las vegas by your side can help make all the difference.

  • women icon

    #WomenInvested

    Work with an advisor bank of america healthcare conference 2019 las vegas help you take care of your full financial life, from big questions to the bigger picture.

  • government icon

    Washington Update

    Latest insights on tax proposals and other policy changes that could affect your financial life.

  • Barron’s Top 1, Financial Advisors

    Merrill has the most advisors on the list.

  • Financial Advisor icon

    New to Merrill?

    Have an advisor call you to discuss your goals. Just answer a few short questions to get started.

Источник: mynewextsetup.us

Kura Oncology to Present at Bank of America Merrill Lynch Health Care Conference

, (GLOBE NEWSWIRE) -- (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced thatPh.D., J.D., President and Chief Executive Officer, is scheduled to present at the on at /. The conference will be held in .

A live audio webcast of the presentation will be available in the Investors section of Kura’s website at mynewextsetup.us, with an archived replay available for 30 days following the event.

About

is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s lead drug candidate is tipifarnib, a farnesyl transferase inhibitor, for which the Company has initiated a registration-directed trial of tipifarnib in recurrent or metastatic patients with HRAS mutant HNSCC. In addition, tipifarnib is being evaluated in multiple other Phase 2 clinical trials in solid tumor and hematologic indications. Kura’s pipeline also includes KO, an ERK inhibitor, currently in a Phase 1 dose-escalation trial, and KO, a menin-MLL inhibitor, which has been cleared to begin a Phase 1 clinical trial. For bank of america healthcare conference 2019 las vegas information about Kura, please visit the Company’s website at mynewextsetup.us

Contacts

Company:

Vice President, Investor Relations &
Corporate Communications
()
[email protected]

Investors:

Managing Director
Westwicke Partners, LLC
()
[email protected]

Media:

Managing Director
Canale Communications
()
[email protected]

Kura Oncology Logo

Source: Kura Oncology, Inc.

Источник: mynewextsetup.us

Integra LifeSciences to participate in Bank of America Merrill Lynch Healthcare Conference in May

PLAINSBORO, N.J., April 30, (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in May:

  • On Tuesday, May 14, at p.m. PT, Sravan Emany, senior vice president - strategy, treasury and investor relations, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas, NV.  

About Integra LifeSciences

Integra LifeSciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, CertasTM, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®, SurgiMend®, TCC-EZ®, Titan™ and VersaTru™.  For the latest news and information about Integra and its brands, please visit mynewextsetup.us.

Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of Such forward-looking statements involve risks and uncertainties that could cause actual bank of america healthcare conference 2019 las vegas to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item 1A of Integra's Annual Report on Form K for the year ended December 31, and information contained in subsequent filings with the Securities and Exchange Commission could affect can i withdraw cash from hsa debit card results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contacts:
Sravan Emany
Senior Vice President – Strategy, Treasury & Investor Relations
()
[email protected]

Michael Beaulieu
Director, Investor Relations
()
[email protected]

Media Contact:
Laurene Isip
Senior Director, Global Corporate Communications
()
[email protected]

Источник: mynewextsetup.us

You can watch a thematic video

Bank of America - The Power to Be Me (2019 Commercial)

Bank of america healthcare conference 2019 las vegas -

Integra LifeSciences to participate in Bank of America Merrill Lynch Healthcare Conference in May

PLAINSBORO, N.J., April 30, (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in May:

  • On Tuesday, May 14, at p.m. PT, Sravan Emany, senior vice president - strategy, treasury and investor relations, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas, NV.  

About Integra LifeSciences

Integra LifeSciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, CertasTM, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®, SurgiMend®, TCC-EZ®, Titan™ and VersaTru™.  For the latest news and information about Integra and its brands, please visit mynewextsetup.us.

Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item 1A of Integra's Annual Report on Form K for the year ended December 31, and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contacts:
Sravan Emany
Senior Vice President – Strategy, Treasury & Investor Relations
()
[email protected]

Michael Beaulieu
Director, Investor Relations
()
[email protected]

Media Contact:
Laurene Isip
Senior Director, Global Corporate Communications
()
[email protected]

Источник: mynewextsetup.us

Homology Medicines to Present at Bank of America Merrill Lynch Health Care Conference

BEDFORD, Mass., May 9, – Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will participate during a fireside chat at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, at p.m. PT at the Encore Hotel in Las Vegas.  In addition, Arthur Tzianabos, Ph.D., President and Chief Executive Officer of Homology Medicines, will participate in the Gene Therapy Panel being held at the conference on Wednesday, May 15, at p.m. PT (not webcast).

The live webcast of the fireside chat will be accessible on Homology’s website in the Investors section, and the webcast replay will be available on the website for 90 days following the presentation.

About Homology Medicines, Inc.
Homology Medicines, Inc. is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines. For more information, please visit mynewextsetup.us

< BACKИсточник: mynewextsetup.us

The right guidance can unlock new possibilities. Watch our videos to see how having a Merrill advisor by your side can help make all the difference.

  • women icon

    #WomenInvested

    Work with an advisor to help you take care of your full financial life, from big questions to the bigger picture.

  • government icon

    Washington Update

    Latest insights on tax proposals and other policy changes that could affect your financial life.

  • Forbes Wealth Advisors icon

    Barron’s Top 1, Financial Advisors

    Merrill has the most advisors on the list.

  • Financial Advisor icon

    New to Merrill?

    Have an advisor call you to discuss your goals. Just answer a few short questions to get started.

Источник: mynewextsetup.us

DALLAS, May 10, (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (CSU), one of the nation’s largest operators of senior living communities, today announced that management will make a presentation regarding the Company at the Bank of America Merrill Lynch Health Care Conference at The Encore in Las Vegas, Nevada on Wednesday, May 15, at p.m. Pacific time.

The presentation is also being audio webcast live and can be accessed on the Internet at mynewextsetup.us until August 13, In addition, the webcast will be available for replay through the Company’s Investor Relations section on their website at mynewextsetup.us for a period of 90 days after the date of the presentation.

ABOUT THE COMPANY

Dallas-based Capital Senior Living Corporation is one of the nation’s largest operators of independent living, assisted living and memory care communities for senior adults. The Company’s communities are home to nearly 12, residents across 23 states and provide compassionate, resident-centric service and care as well as engaging programming. Capital Senior Living offers seniors the freedom and opportunity to successfully, comfortably and happily age in place. For more information, visit mynewextsetup.us or connect with the Company on Facebook.

Contact Carey P. Hendrickson, Chief Financial Officer, at for more information.

Источник: mynewextsetup.us

PARSIPPANY, N.J(BUSINESS WIRE)--May 7, The Medicines Company (NASDAQ:MDCO) announced that it will participate in the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 14, , in Las Vegas. The Company is scheduled to present at a.m. Pacific Time ( a.m. Eastern Time).

A live audio webcast will be available on The Medicines Company Investor Relations website and a replay of the presentation will be available within 48 hours of the event.

About The Medicines Company

The Medicines Company is a biopharmaceutical company whose purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C, or bad cholesterol. Our team is focused on transformational solutions that address the daily challenges that patients, physicians and payers confront in cardiovascular care. The Company is headquartered in Parsippany, New Jersey. For more information, please visit mynewextsetup.us and follow us on Twitter @MDCONews and LinkedIn.

View source version on mynewextsetup.us:mynewextsetup.us

CONTACT: Investor Relations

Krishna Gorti, M.D.

Vice President, Investor Relations

[email protected] Inquiries

Michael Blash

Vice President, Communications

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA NEVADA NEW JERSEY

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CARDIOLOGY PHARMACEUTICAL

SOURCE: The Medicines Company

Copyright Business Wire

PUB: 05/07/ AM/DISC: 05/07/ AM

mynewextsetup.us

Источник: mynewextsetup.us

Boston Scientific to Participate in Bank of America Merrill Lynch Healthcare Conference

 

MARLBOROUGH, Mass., May 1, /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, in Las Vegas.

Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)

Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a minute question-and-answer session with the host analyst beginning at approximately a.m. PDT / a.m. EDT.  A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at mynewextsetup.us

A replay of the webcast will be accessible at mynewextsetup.us beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit mynewextsetup.us and connect on Twitter and Facebook.

CONTACTS

 

 

Cision View original content to download multimedia:mynewextsetup.us

SOURCE Boston Scientific

 
Источник: mynewextsetup.us

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *